Journal of Oral Pathology & Medicine

Papers
(The H4-Index of Journal of Oral Pathology & Medicine is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
55
It was not possible to detect BRAF V600E mutation in circulating cell‐free DNA from patients with ameloblastoma: A diagnostic accuracy study34
Global Research Trends on the Links Between the Oral Microbiome and Cancer From 2014 to 2024: A Visualization Analysis33
Calibration improves the agreement in grading oral epithelial dysplasia—Findings from a National Workshop in Malaysia27
Is vitamin D receptor (VDR) polymorphism associated with head and neck cancer risk? A systematic review and meta‐analysis27
Whole‐exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes27
Impact of Information Provided in Remote Case Discussions on Oral Medicine Teleconsultants' Diagnostic Impression24
GPRASP1 is a candidate anti‐oncogene and correlates with immune microenvironment and immunotherapeutic efficiency in head and neck cancer22
22
Evaluating Temporomandibular Disorder Severity: A Four‐Dimensional Model22
21
Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient21
HPV‐Vaccine and Reduced Odds Ratio for Oral and Oropharyngeal Cancer in Both Genders21
The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia21
The FUS/COL11A1/ZEB1 Axis Contributes to the Development of Oral Squamous Cell Carcinoma21
Immunohistochemical biomarkers in oral submucous fibrosis: A scoping review21
Correction to “Synergistic Effect of Honokiol and 5‐Fluorouracil on Apoptosis of Oral Squamous Cell Carcinoma Cells”20
Long‐term effectiveness of a novel intra‐oral electro‐stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham‐controlled feasibility study (LEO20
HAGLROS promotes cell proliferation and angiogenesis and inhibits apoptosis by activating multiple signaling pathways in LSCC cells20
Issue Information19
19
Association of dipeptidyl peptidase IV polymorphism with clinicopathological characters of oral cancer19
0.11981105804443